Eurofins Scientific SE
Eurofins Scientific SE ERF.PA Peers
See (ERF.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ERF.PA | $55.14 | -1.78% | 9.70B | 26.38 | $2.09 | +1.99% |
| BIM.PA | $117.90 | +0.26% | 13.90B | 32.30 | $3.65 | +0.72% |
| LBIRD.PA | $12.25 | +1.66% | 269.63M | 47.12 | $0.26 | N/A |
| ALECR.PA | $20,600.00 | N/A | 103.91M | 14.33 | $1,437.88 | N/A |
| MDXH.BR | $3.02 | -3.76% | 85.63M | -1.58 | -$1.91 | N/A |
| BCART.BR | $0.29 | N/A | 27.24M | -0.32 | -$0.92 | N/A |
| ALBIO.PA | $1.24 | +0.24% | 22.46M | -0.43 | -$2.86 | N/A |
| ALPRE.PA | $3.77 | +0.51% | 14.10M | -3.02 | -$1.25 | N/A |
| EEP.MC | $0.54 | N/A | 6.26M | -54.00 | -$0.01 | N/A |
| MLAHC.PA | $0.60 | N/A | 5.41M | -10.00 | -$0.06 | N/A |
Stock Comparison
ERF.PA vs BIM.PA Comparison
ERF.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERF.PA stands at 9.70B. In comparison, BIM.PA has a market cap of 13.90B. Regarding current trading prices, ERF.PA is priced at $55.14, while BIM.PA trades at $117.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERF.PA currently has a P/E ratio of 26.38, whereas BIM.PA's P/E ratio is 32.30. In terms of profitability, ERF.PA's ROE is +0.05%, compared to BIM.PA's ROE of +0.11%. Regarding short-term risk, ERF.PA is more volatile compared to BIM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ERF.PA.